What could health systems achieve by improving access to and use of guideline-directed medical therapy?
Drawing on the Global PAH Study's novel research and modelling, this report examines the potential impact of increased guideline-directed medical therapy (GDMT) adoption across five major chronic conditions and the opportunity to reduce potentially avoidable hospitalisations.
The report highlights the growing burden on patients and health systems, introduces a four-lever roadmap for change, and a set of prioritised recommendations for policymakers, payers, and health-system leaders.
Levers to optimise GDMT uptake and reduce potentially avoidable hospitalisations
Coordinated care
Incentives
Equitable access
Long-term budgeting
